SCHEMBL7093808

SCHEMBL7093808

C#CC(CF)(CF)OS(=O)(=O)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.34
TDP1 Q9NUW8 2/20 0.34
PARL Q9H300 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
PSIP1 O75475 1/20 0.33
HTR6 P50406 1/20 0.33
KEAP1 Q14145 2/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
APOBEC3G Q9HC16 1/20 0.32
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
MMP8 P22894 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7093841 0.84 ALDH1A1 (0.38) ALDH1A1HPGDKMT2ALMNASMN1; SMN2
SCHEMBL7096208 0.84 ALDH1A1 (0.37) ALDH1A1TDP1KDM4EKMT2ACA1
SCHEMBL4135164 0.77 PSIP1 (0.41) ALDH1A1TDP1PARLKDM4EMAPT
SCHEMBL8136181 0.75 HTR6 (0.38) ALDH1A1TDP1PARLKDM4EMAPT
SCHEMBL16649192 0.74 ALDH1A1 (0.40) ALDH1A1TDP1PARLKDM4EMAPT
SCHEMBL1515703 0.70 HTR6 (0.44) ALDH1A1TDP1PARLKDM4EMAPT
SCHEMBL16046048 0.69 PSIP1 (0.43) ALDH1A1TDP1PARLKDM4EMAPT
SCHEMBL28361716 0.69 HTR6 (0.42) ALDH1A1TDP1PARLKDM4EMAPT
Ammonia Solution, Strong SCHEMBL27662422 0.69 HTR6 (0.42) ALDH1A1TDP1PARLKDM4EMAPT
SCHEMBL7091766 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065189-A1 Processes for producing 4-substituted benzopyran derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-03 US disclosed
US-6455708-B1 SUCH AS 2,2-BIS(FLUOROMETHYL)-N-(2-CYANOETHYL)-6-TRIFLUOROMETHYL-2H-1-BENZOPYRAN-4 -CARBOXAMIDE; USEFUL AS MEDICINES, AGRICHEMICALS AND COSMETICS, AND CHEMICAL INTERMEDIATES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-09-24 US disclosed
EP-1120412-A1 PROCESSES FOR THE PREPARATION OF 4-SUBSTITUTED BENZOPYRAN DERIVATIVES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2001-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065189-A1 Processes for producing 4-substituted benzopyran derivatives CYP3A4, PARP14, BTD ALDH1A1 1038/4885TDP1 1666/4885PARL 2772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.